Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays
暂无分享,去创建一个
Arvydas Laurinavicius | Aida Laurinaviciene | V. Ostapenko | A. Laurinavičienė | A. Laurinavičius | S. Jarmalaitė | J. Lazutka | Darius Dasevicius | Valerijus Ostapenko | Sonata Jarmalaite | Juozas Lazutka | Darius Dasevičius | D. Dasevičius
[1] Jinha M. Park,et al. Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials , 2005, Clinical Cancer Research.
[2] Laoighse Mulrane,et al. Automated image analysis in histopathology: a valuable tool in medical diagnostics , 2008, Expert review of molecular diagnostics.
[3] Janina Słodkowska,et al. Study on breast carcinoma Her2/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio). , 2010, Folia histochemica et cytobiologica.
[4] U. Vogel. Confirmation of a low HER2 positivity rate of breast carcinomas - limitations of immunohistochemistry and in situ hybridization , 2010, Diagnostic pathology.
[5] Klaus Kayser,et al. Quantification of virtual slides: Approaches to analysis of content-based image information , 2011, Journal of pathology informatics.
[6] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[7] Jan P. A. Baak,et al. Digital Image Analysis Improves the Quality of Subjective HER-2 Expression Scoring in Breast Cancer , 2008, Applied immunohistochemistry & molecular morphology : AIMM.
[8] P. Klein,et al. Concordance between central and local laboratory HER2 testing from a community-based clinical study. , 2006, Clinical breast cancer.
[9] D. Faratian,et al. Tissue microarray technology in the routine assessment of HER‐2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization , 2008, Histopathology.
[10] Aldo Badano,et al. Observer variability in the interpretation of HER2/neu immunohistochemical expression with unaided and computer-aided digital microscopy. , 2011, Archives of pathology & laboratory medicine.
[11] D. Slamon,et al. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Søren Nielsen,et al. Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains , 2012, Breast Cancer Research and Treatment.
[13] David J. Foran,et al. Computer-assisted assessment of the Human Epidermal Growth Factor Receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quantitative analysis of positive controls , 2008, BMC Medical Imaging.
[14] M. Henry,et al. Automated cellular imaging system III for assessing HER2 status in breast cancer specimens: development of a standardized scoring method that correlates with FISH. , 2009, American journal of clinical pathology.
[15] Kyle J. Myers,et al. Automated Quantitative Assessment of HER-2/neu Immunohistochemical Expression in Breast Cancer , 2009, IEEE Transactions on Medical Imaging.
[16] G. Viale,et al. Pathological definition of triple negative breast cancer. , 2009, European journal of cancer.
[17] P. Pauwels,et al. Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerations , 2010, Journal of Clinical Pathology.
[18] E. Perez,et al. HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Sean Davis,et al. Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic Studies , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[20] Peter A Kaufman,et al. Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831. , 2002, Journal of the National Cancer Institute.
[21] Determination of HER-2 status and chromosome 17 polysomy in breast carcinomas comparing HercepTest and PathVysion FISH assay. , 2004, American journal of clinical pathology.
[22] Kelli Montgomery,et al. Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis , 2009, BMC Cancer.
[23] J. Ross,et al. Human epidermal growth factor receptor 2 testing in 2010: does chromosome 17 centromere copy number make any difference? , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] S. Nofech-Mozes,et al. Intratumoral Heterogeneity of HER2/neu in Breast Cancer—A Rare Event , 2007, The breast journal.
[25] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.
[26] Dylan Reilly,et al. Standardization of HER2 immunohistochemistry in breast cancer by automated quantitative analysis. , 2009, Archives of pathology & laboratory medicine.
[27] Kyle Porter,et al. Semi‐automated imaging system to quantitate Her‐2/neu membrane receptor immunoreactivity in human breast cancer , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[28] Marilyn M. Bui,et al. Using image analysis as a tool for assessment of prognostic and predictive biomarkers for breast cancer: How reliable is it? , 2010, Journal of pathology informatics.
[29] J. Baak,et al. Comparing subjective and digital image analysis HER2/neu expression scores with conventional and modified FISH scores in breast cancer , 2007, Journal of Clinical Pathology.
[30] Lynne Dobson,et al. Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretation , 2010, Histopathology.
[31] Paul J Tadrous,et al. On the concept of objectivity in digital image analysis in pathology , 2010, Pathology.
[32] D. Rimm,et al. Immunohistochemistry and quantitative analysis of protein expression. , 2009, Archives of pathology & laboratory medicine.
[33] Z. Gatalica,et al. Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17 , 2011, Cancer.
[34] D. Soenksen. Digital pathology at the crossroads of major health care trends: corporate innovation as an engine for change. , 2009, Archives of pathology & laboratory medicine.